Back
CVS Health Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
58
CVS
CVS Health
Last Price:
61.40
Seasonality Move:
-0.72%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Buy
58
CVS Health (CVS)
is a Buy
Is CVS Health a Buy, Sell or Hold?
- The current CVS Health [CVS] share price is $61.38. The Score for CVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- CVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CVS Stock Price Chart
What is CVS Health's stock price today?
-
The CVS Health share price today is $61.38
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.43
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
CVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 66.25 | Buy |
Chaikin Money Flow: | 7829653 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.93 - 58.99) | Buy |
Bollinger Bands (100): | (56.46 - 60.2) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 43.18 | Sell |
Chaikin Money Flow: | -435004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.76 - 58.26) | Sell |
Bollinger Bands (100): | (40.14 - 54.08) | Buy |
CVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.63 | Buy |
20-day SMA: | 58 | Buy |
50-day SMA: | 58.25 | Buy |
200-day SMA: | 66.35 | Sell |
8-day EMA: | 58.94 | Buy |
20-day EMA: | 58.32 | Buy |
50-day EMA: | 58.46 | Buy |
200-day EMA: | 63.93 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.08 | Sell |
20-day SMA: | 56.96 | Sell |
50-day SMA: | 52.99 | Buy |
200-day SMA: | 46.88 | Buy |
8-day EMA: | 56.5 | Sell |
20-day EMA: | 56.46 | Sell |
50-day EMA: | 53.4 | Buy |
200-day EMA: | 47.32 | Buy |
CVS Health Earnings Growth & CVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.42 per share, an increase next quarter of $0.26 per share, a decrease this year of $2.07 per share, and an increase next year of $0.79 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
CVS Health Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |